Discover how to benefit from:
Translational Pharmaceutics® accelerates drug development by integrating formulation development, real-time manufacturing, and clinical testing. Over the past decade, it has been used widely by pharmaceutical and biotech companies on >400 programs to advance molecules across the full development cycle, from first-in-human (FIH) trials to market. Key applications within the development process include:
The Tufts CSDD compared the cycle times of traditional drug development programs to Translational Pharmaceutics® programs and their derivative effects on development economics. These data were incorporated in a drug development model and the financial benefits were quantified on industry R&D costs and returns. The model assessed several different project types and the top line results included mean financial benefits exceeding $100 million and mean timeline savings of >12 months.